REQUEST A DEMO
Total
USD $0.00
Search more companies

Megat - Pharmaceutical S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Megat - Pharmaceutical S.A. Profile Updated: February 11, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Megat - Pharmaceutical S.A. is based in Ecuador, with the head office in Quito. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on May 23, 2017. Megat - Pharmaceutical S.A. currently employs 41 (2024) people. From the latest financial highlights, Megat - Pharmaceutical S.A. reported a net sales revenue increase of 452.17% in 2024. Its’ total assets recorded a growth of 113.74%. In 2024, Megat - Pharmaceutical S.A.’s net profit margin decreased by 38.27%.

Headquarters
Rumipamba E2-194
Quito; Pichincha;

Contact Details: Purchase the Megat - Pharmaceutical S.A. report to view the information.

Website: http://www.megat.com.ec

Basic Information
Total Employees:
Purchase the Megat - Pharmaceutical S.A. report to view the information.
Registered Capital:
Purchase the Megat - Pharmaceutical S.A. report to view the information.
Financial Auditors:
Purchase the Megat - Pharmaceutical S.A. report to view the information.
Incorporation Date:
May 23, 2017
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99.92%
Purchase this report to view the information.
0.08%
Company Performance
Financial values in the chart are available after Megat - Pharmaceutical S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
452.17%
Total operating revenue
662.66%
Operating profit (EBIT)
-580.72%
EBITDA
-627.57%
Net Profit (Loss) for the Period
-590.17%
Total Assets
113.74%
Total Equity
N/A
Operating Profit Margin (ROS)
-33.84%
Net Profit Margin
-38.27%
Return on Equity (ROE)
N/A
Quick Ratio
-0.5%
Cash Ratio
-0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?